Type 2 Diabetes Global Clinical Trials Review, Q4, 2010
Publisher Name » GlobalData
Published Date » 2010-12-30
No. Of Pages » 104
GlobalData's clinical trial report, “Type II Diabetes Global Clinical Trials Review, Q4, 2010"" provides data on the Type II Diabetes clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Type II Diabetes. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Type II Diabetes).
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade
- Number of clinical trials segmented by key drugs
- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Type 2 diabetes 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Type 2 diabetes 21
Subjects Recruited Over a Period of Time 32
Prominent Sponsors 33
Prominent Sponsors 33
Top Companies Participating in Type 2 Diabetes Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
AstraZeneca PLC 37
Clinical Trial Overview of AstraZeneca PLC 37
Merck & Co., Inc. 41
Clinical Trial Overview of Merck & Co., Inc. 41
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
Novo Nordisk A/S 48
Clinical Trial Overview of Novo Nordisk A/S 48
Pfizer Inc. 51
Clinical Trial Overview of Pfizer Inc. 51
Sanofi-Aventis 54
Clinical Trial Overview of Sanofi-Aventis 54
Eli Lilly and Company 57
Clinical Trial Overview of Eli Lilly and Company 57
GlaxoSmithKline plc 59
Clinical Trial Overview of GlaxoSmithKline plc 59
Novartis AG 61
Clinical Trial Overview of Novartis AG 61
Amylin Pharmaceuticals, Inc. 64
Clinical Trial Overview of Amylin Pharmaceuticals, Inc. 64
Boehringer Ingelheim GmbH 67
Clinical Trial Overview of Boehringer Ingelheim GmbH 67
Takeda Pharmaceutical Company Limited 70
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 70
Johnson & Johnson 72
Clinical Trial Overview of Johnson & Johnson 72
Astellas Pharma Inc. 73
Clinical Trial Overview of Astellas Pharma Inc. 73
Daiichi Sankyo Company, Ltd 74
Clinical Trial Overview of Daiichi Sankyo Company, Ltd 74
MannKind Corporation 75
Clinical Trial Overview of MannKind Corporation 75
Abbott Laboratories 76
Clinical Trial Overview of Abbott Laboratories 76
F. Hoffmann-La Roche Ltd. 77
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 77
Mitsubishi Tanabe Pharma Corporation 78
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 78
Roche Pharma AG 79
Clinical Trial Overview of Roche Pharma AG 79
Clinical Trial Overview of Top Universities / Institutes / Hospitals 80
The National Institute of Diabetes and Digestive and Kidney Diseases 80
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 80
Vanderbilt University 82
Clinical Trial Overview of Vanderbilt University 82
Park Nicollet Institute 83
Clinical Trial Overview of Park Nicollet Institute 83
Aarhus University 84
Clinical Trial Overview of Aarhus University 84
The University of Texas Southwestern Medical Center at Dallas 85
Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas 85
Kaleida Health 86
Clinical Trial Overview of Kaleida Health 86
Endocrine Research Society 87
Clinical Trial Overview of Endocrine Research Society 87
Washington University School of Medicine 88
Clinical Trial Overview of Washington University School of Medicine 88
University of Alberta 89
Clinical Trial Overview of University of Alberta 89
The University of British Columbia 90
Clinical Trial Overview of The University of British Columbia 90
The University of Chicago 91
Clinical Trial Overview of The University of Chicago 91
The Ohio State University 92
Clinical Trial Overview of The Ohio State University 92
Odense University Hospital 93
Clinical Trial Overview of Odense University Hospital 93
Albert Einstein College of Medicine of Yeshiva University 94
Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University 94
Aristotle University Of Thessaloniki 95
Clinical Trial Overview of Aristotle University Of Thessaloniki 95
The University of Texas Health Science Center at San Antonio 96
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 96
Imperial College London 97
Clinical Trial Overview of Imperial College London 97
University Hospitals of Leicester NHS Trust 98
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 98
University of Toronto 99
Clinical Trial Overview of University of Toronto 99
Mayo Clinic 100
Clinical Trial Overview of Mayo Clinic 100
Appendix 101
Abbreviations 101
Definitions 102
Research Methodology 102
Secondary Research 103
About GlobalData 103
Contact Us 104
Disclaimer 104
Source 104
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Zone, 2010* 9
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 10
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010* 11
Type 2 Diabetes Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2010* 12
Type 2 Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries, 2010* 13
Type 2 Diabetes Therapeutics Clinical Trials, North America, Top Countries, 2010* 14
Type 2 Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2010* 15
Type 2 Diabetes Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2010* 16
Type 2 Diabetes Therapeutics Clinical Trials, BRIC Countries, 2010* 17
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Phase, 2010* 18
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials in Progress by Phase 2010* 19
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 20
Type 2 Diabetes Therapeutics Market, Global, Suspended Clinical Trials, 2010* 21
Type 2 Diabetes Therapeutics Market, Global, Withdrawn Clinical Trials, 2010* 22
Type 2 Diabetes Therapeutics Market, Global, Terminated Clinical Trials, 2010* 23
Type 2 Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 32
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 33
Type 2 Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 35
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 36
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2010* 37
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2010* 41
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2010* 44
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2010* 48
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2010* 51
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2010* 54
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2010* 57
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2010* 59
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2010* 61
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Amylin Pharmaceuticals, Inc., 2010* 64
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2010* 67
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2010* 70
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2010* 72
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2010* 73
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Ltd, 2010* 74
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind Corporation, 2010* 75
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2010* 76
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2010* 77
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2010* 78
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Roche Pharma AG, 2010* 79
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2010* 80
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2010* 82
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Park Nicollet Institute, 2010* 83
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2010* 84
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2010* 85
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaleida Health, 2010* 86
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Endocrine Research Society, 2010* 87
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2010* 88
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2010* 89
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2010* 90
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2010* 91
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2010* 92
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2010* 93
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2010* 94
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2010* 95
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2010* 96
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2010* 97
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2010* 98
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2010* 99
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2010* 100
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 9
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 10
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010* 11
Type 2 Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010* 12
Type 2 Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 13
Type 2 Diabetes Therapeutics Clinical Trials, North America, Top Countries (%), 2010* 14
Type 2 Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2010* 15
Type 2 Diabetes Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2010* 16
Type 2 Diabetes Therapeutics Clinical Trials, BRIC Countries (%), 2010* 17
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 18
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 19
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 20
Type 2 Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 32
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 33
Type 2 Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 34
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 36
GlobalData Methodology 103
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Type 2 diabetes 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Type 2 diabetes 21
Subjects Recruited Over a Period of Time 32
Prominent Sponsors 33
Prominent Sponsors 33
Top Companies Participating in Type 2 Diabetes Therapeutics Clinical Trials 34
Prominent Drug Comparison 36
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
AstraZeneca PLC 37
Clinical Trial Overview of AstraZeneca PLC 37
Merck & Co., Inc. 41
Clinical Trial Overview of Merck & Co., Inc. 41
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
Novo Nordisk A/S 48
Clinical Trial Overview of Novo Nordisk A/S 48
Pfizer Inc. 51
Clinical Trial Overview of Pfizer Inc. 51
Sanofi-Aventis 54
Clinical Trial Overview of Sanofi-Aventis 54
Eli Lilly and Company 57
Clinical Trial Overview of Eli Lilly and Company 57
GlaxoSmithKline plc 59
Clinical Trial Overview of GlaxoSmithKline plc 59
Novartis AG 61
Clinical Trial Overview of Novartis AG 61
Amylin Pharmaceuticals, Inc. 64
Clinical Trial Overview of Amylin Pharmaceuticals, Inc. 64
Boehringer Ingelheim GmbH 67
Clinical Trial Overview of Boehringer Ingelheim GmbH 67
Takeda Pharmaceutical Company Limited 70
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 70
Johnson & Johnson 72
Clinical Trial Overview of Johnson & Johnson 72
Astellas Pharma Inc. 73
Clinical Trial Overview of Astellas Pharma Inc. 73
Daiichi Sankyo Company, Ltd 74
Clinical Trial Overview of Daiichi Sankyo Company, Ltd 74
MannKind Corporation 75
Clinical Trial Overview of MannKind Corporation 75
Abbott Laboratories 76
Clinical Trial Overview of Abbott Laboratories 76
F. Hoffmann-La Roche Ltd. 77
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 77
Mitsubishi Tanabe Pharma Corporation 78
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 78
Roche Pharma AG 79
Clinical Trial Overview of Roche Pharma AG 79
Clinical Trial Overview of Top Universities / Institutes / Hospitals 80
The National Institute of Diabetes and Digestive and Kidney Diseases 80
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 80
Vanderbilt University 82
Clinical Trial Overview of Vanderbilt University 82
Park Nicollet Institute 83
Clinical Trial Overview of Park Nicollet Institute 83
Aarhus University 84
Clinical Trial Overview of Aarhus University 84
The University of Texas Southwestern Medical Center at Dallas 85
Clinical Trial Overview of The University of Texas Southwestern Medical Center at Dallas 85
Kaleida Health 86
Clinical Trial Overview of Kaleida Health 86
Endocrine Research Society 87
Clinical Trial Overview of Endocrine Research Society 87
Washington University School of Medicine 88
Clinical Trial Overview of Washington University School of Medicine 88
University of Alberta 89
Clinical Trial Overview of University of Alberta 89
The University of British Columbia 90
Clinical Trial Overview of The University of British Columbia 90
The University of Chicago 91
Clinical Trial Overview of The University of Chicago 91
The Ohio State University 92
Clinical Trial Overview of The Ohio State University 92
Odense University Hospital 93
Clinical Trial Overview of Odense University Hospital 93
Albert Einstein College of Medicine of Yeshiva University 94
Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University 94
Aristotle University Of Thessaloniki 95
Clinical Trial Overview of Aristotle University Of Thessaloniki 95
The University of Texas Health Science Center at San Antonio 96
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 96
Imperial College London 97
Clinical Trial Overview of Imperial College London 97
University Hospitals of Leicester NHS Trust 98
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 98
University of Toronto 99
Clinical Trial Overview of University of Toronto 99
Mayo Clinic 100
Clinical Trial Overview of Mayo Clinic 100
Appendix 101
Abbreviations 101
Definitions 102
Research Methodology 102
Secondary Research 103
About GlobalData 103
Contact Us 104
Disclaimer 104
Source 104
List of Tables
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Zone, 2010* 9
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 10
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010* 11
Type 2 Diabetes Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2010* 12
Type 2 Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries, 2010* 13
Type 2 Diabetes Therapeutics Clinical Trials, North America, Top Countries, 2010* 14
Type 2 Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2010* 15
Type 2 Diabetes Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2010* 16
Type 2 Diabetes Therapeutics Clinical Trials, BRIC Countries, 2010* 17
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Phase, 2010* 18
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials in Progress by Phase 2010* 19
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 20
Type 2 Diabetes Therapeutics Market, Global, Suspended Clinical Trials, 2010* 21
Type 2 Diabetes Therapeutics Market, Global, Withdrawn Clinical Trials, 2010* 22
Type 2 Diabetes Therapeutics Market, Global, Terminated Clinical Trials, 2010* 23
Type 2 Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 32
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 33
Type 2 Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 35
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 36
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2010* 37
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2010* 41
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2010* 44
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2010* 48
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2010* 51
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2010* 54
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2010* 57
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2010* 59
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2010* 61
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Amylin Pharmaceuticals, Inc., 2010* 64
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2010* 67
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2010* 70
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2010* 72
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2010* 73
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Ltd, 2010* 74
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind Corporation, 2010* 75
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2010* 76
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2010* 77
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2010* 78
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Roche Pharma AG, 2010* 79
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2010* 80
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2010* 82
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Park Nicollet Institute, 2010* 83
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2010* 84
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Southwestern Medical Center at Dallas, 2010* 85
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaleida Health, 2010* 86
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Endocrine Research Society, 2010* 87
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2010* 88
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2010* 89
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of British Columbia, 2010* 90
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2010* 91
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2010* 92
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2010* 93
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2010* 94
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2010* 95
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at San Antonio, 2010* 96
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2010* 97
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2010* 98
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2010* 99
Type 2 Diabetes Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2010* 100
List of Figures
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Zone (%), 2010* 9
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 10
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010* 11
Type 2 Diabetes Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010* 12
Type 2 Diabetes Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 13
Type 2 Diabetes Therapeutics Clinical Trials, North America, Top Countries (%), 2010* 14
Type 2 Diabetes Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2010* 15
Type 2 Diabetes Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2010* 16
Type 2 Diabetes Therapeutics Clinical Trials, BRIC Countries (%), 2010* 17
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 18
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010* 19
Type 2 Diabetes Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 20
Type 2 Diabetes Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2009 32
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 33
Type 2 Diabetes Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 34
Type 2 Diabetes Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 36
GlobalData Methodology 103
Upcoming Reports:
|
Smart Airports Market - Global Industry Analysis, Market Size, Share, Growth, Trends, And Forecast, 2012 - 2018
By - Transparency Market Research
Airport operations and business models have evolved dramatically over the last two decades to support the explosive growth of the global airline industry. Regulatory reform and deregulation ushered in a new aviation era in North America, as well as in Europe, Asia, and in emerging countries, producing dramatic traffic growth, diversity, and choice for airline passengers.
Shifting demographics, new corporate governance requirements, and emerging and maturing communication technologies are driving new travel patterns that will require innovative business models and...
|
|
Power Lawn And Garden Equipment Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
Demand for power lawn and garden equipment is rising considerably mainly because of improvements in housing activities like new construction and single family home sales. Currently, the residential market dominates the power lawn and garden equipment market owing to increasing concerns of people towards gardens. Also, this market is gaining momentum in the commercial sector, particularly golf courses. Government funding and positive response from private firms for development of landscapes is expected to double the growth rate of this market.
Market...
|
|
Synthetic and Bio-Based Butadiene Market: Industry Overview, Applications and Downstream Potential Opportunities, 2010 - 2018
By - Transparency Market Research
1,3-Butadiene, frequently referred to as butadiene, is a simple conjugated diene with the chemical formula C4H6. It is predominantly used as a monomer for producing synthetic rubber in industries. It is produced as a byproduct of the steam cracking used for producing ethylene and olefins; it is also produced from dehydrogenation of n-butane. The global demand of butadiene has been increasing as main application of butadiene is in the production of acrylonitrile butadiene styrene and styrene butadiene rubber which is basically used for manufacturing automotive tires....
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- The Future of the Haircare Market in Egypt to 2017
- The Future of the Haircare Market in Denmark to 2017
- Overview of international chemical market
- Russian market of microcredits and lending to SME in Russia
- Overview of furniture market
- Global and China Piano Industry Report, 2012-2013
- The Future of the Haircare Market in Czech Republic to 2017
- LTE Strategy 2013 - 2018
- Natural And Synthetic (Ethoxyquin, BHA, BHT) Animal Feed Antioxidants Market For Swine, Poultry, Cattle And Aquaculture - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Seed Treatment Market (Insecticides, Fungicides, Other Chemical And Nonchemical Treatment) For Corn, Soybean, Wheat, Canola, Cotton And Others - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
